Pictured: William Alago
Q&A
By Maureen Salamon, BA, Freelance Writer  |  Monday, November 24, 2014

Interventional radiologist William Alago discusses minimally invasive procedures, advances in imaging techniques, and the future of his field.

Pictured: Jedd Wolchok, Alexandra Snyder Charen and Timothy Chan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 20, 2014

In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system.

Michel Sadelain and Prasad Adusumilli
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, November 19, 2014

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.

(From left) MSK investigators Michael Berger, José Baselga, and Maurizio Scaltriti, and graduate student Pau Castel.
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 17, 2014

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.

Gregory Riely
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, November 12, 2014

MSK lung cancer patients benefit from a powerful genomic test that looks for mutations in 341 genes to help determine the best treatment.

Pictured: Joao Xavier & Eric Pamer
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 10, 2014

Clostridium difficile infections are a growing problem, but MSK researchers are looking for innovative ways to prevent and treat them.

RISE Program Clinical Director Debra Mangino discusses next steps with a patient.
In the Clinic
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 31, 2014

The team of experts in our RISE Program tailor each woman’s surveillance plan based on the latest findings in breast cancer risk, prevention, and treatment.

Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, October 20, 2014

Medical oncologist Paul Sabbatini demystifies common misconceptions surrounding clinical trials.

DNA wrapped around histones
Decoder
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, October 14, 2014

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

Pictured: Ping Chi
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, October 9, 2014

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

Pictured: Robin Roberts & Tonya Samuel
SUPPORT
By Maureen Salamon, BA, Freelance Writer  |  Friday, October 3, 2014

For people undergoing bone marrow or stem cell transplants, being isolated from friends, family, and everyday life can make recovery more difficult.

Event
By Jim Stallard, MA, Writer/Editor  |  Thursday, September 25, 2014

Transplant patients at Memorial Sloan Kettering gave support to bone marrow donation efforts with their own “walk” inside the hospital.

Pictured: Paul Sabbatini
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, September 24, 2014

Medical oncologist Paul Sabbatini sheds light on how phase I clinical trials are conducted at Memorial Sloan Kettering and how to determine whether patients may be eligible for one.

Pictured: Experimental Brain Tumor
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 18, 2014

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.

Thoracic surgeon Bernard Park.
Ask the Expert
By Andrea Peirce, BA, Writer/Editor  |  Thursday, August 28, 2014

Less trauma and faster recovery are among the reasons that thoracic surgeon Bernard Park says people should consider robotic surgery for removing a cancer in the chest.

Center News

Stay Informed

Get the latest information about cancer care and research every month.